Dexcom CEO Talks Stelo Launch, Broader Plans, And GLP1 Misconceptions

Medtech Insight spoke to Dexcom CEO Kevin Sayer, ahead of this year’s Advanced Technologies & Treatments for Diabetes conference, to get an update on the company’s recent news, future strategy and where he feels his company’s market is headed.

• Source: Shutterstock

Dexcom perfectly timed a series of announcements with the start of this year’s annual Advanced Technologies & Treatments for Diabetes conference, held in Florence, Italy.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Diabetic Care

More from Device Area